KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,502,703 | -40.9% | 8,887 | -24.2% | 0.00% | -50.0% |
| Q2 2023 | $2,542,784 | +28.3% | 11,726 | +7.4% | 0.00% | +100.0% |
| Q1 2023 | $1,982,601 | -7.5% | 10,915 | +0.0% | 0.00% | -50.0% |
| Q4 2022 | $2,144,209 | +21.8% | 10,912 | +39.5% | 0.00% | +100.0% |
| Q3 2022 | $1,760,000 | +85.9% | 7,823 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $947,000 | +0.1% | 7,483 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $946,000 | -1.0% | 7,462 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $956,000 | -23.2% | 7,293 | -28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,245,000 | +11.6% | 10,176 | +4.0% | 0.00% | 0.0% |
| Q2 2021 | $1,116,000 | 0.0% | 9,786 | +5.4% | 0.00% | 0.0% |
| Q1 2021 | $1,116,000 | +15.6% | 9,283 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $965,000 | +132.0% | 9,499 | +76.5% | 0.00% | – |
| Q3 2020 | $416,000 | -54.5% | 5,381 | -34.4% | 0.00% | -100.0% |
| Q2 2020 | $914,000 | – | 8,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |